An expert in male infertility and prostate cancer, Dr. Peter Schlegel has been named Chairman of the Department of Urology at Weill Cornell Medical College in NewYork City and Urologist-in-Chief at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

America's oldest and most prestigious organization dedicated to purebred dogs is creating a pet therapy program for New York's leading children's hospital with the goal of enhancing the healing process for its pediatric patients.

Injecting a combination of growth factors can protect the heart during a heart attack, NewYork-Presbyterian Hospital/Weill Cornell Medical Center researchers report in this month's issue of the Journal of Experimental Medicine.

A new resource center specifically designed for psychiatric patients and their families has opened at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Named after a beloved Weill Cornell Medical College graduate, the Bruce Hedges, M.D. Patient Resource Center provides comprehensive and up-to-date information about a wide range of psychiatric conditions. Designed to be comfortable and empowering, the new center was built in the spirit of the Hospital's new partnership with the Planetree Alliance, a national organization dedicated to facilitating patient-centric care.

New York City's older adults, physicians, and caregivers now have a unique, new Web site, CornellCARES.com, where comprehensive mental health and psychosocial information and resources are easily accessed. CornellCARES.com, developed and hosted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center, includes a listing of New York City Medicare mental-health providers, and is the first resource of its kind.

Women who regularly take aspirin seem to be at lower risk of the most common type of breast cancer than those who do not take aspirin, report researchers from Columbia University's Mailman School of Public Health and College of Physicians Surgeons, Weill Cornell Medical College, and NewYork-Presbyterian Hospital. Specifically, aspirin may cut the risk of hormone receptor positive breast cancer, which makes up about 60-70% of all breast cancer cases.

Cholesterol-busting statin medications have revolutionized the prevention and treatment of coronary heart disease (CHD), the leading killer of American men and women. But a recent move by the British government toward approval of low-dose, over-the-counter (OTC) simvastatin (Zocor®) has raised heated debate here in the U.S. Now, in his editorial in the September 15 issue of the American Journal of Cardiology, Dr. Antonio M. Gotto, Jr., Professor of Medicine and the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College in New York City, says the proven effectiveness and good safety record of statin medications argues for a similar move in the U.S.

The Division of Cardiology at Weill Cornell Medical College has been named for Maurice R. and Corinne P. Greenberg, generous and longtime benefactors of the Medical College and NewYork-Presbyterian Hospital in many areas, including cardiovascular research and patient care.